INTERVAL CANCERS IN THE SCREENING OF PROSTATE CANCER: RESULTS FROM THE HELSINKI AREA OF THE ERSPC STUDY

被引:0
|
作者
Santti, H. [1 ]
Joutsi, T. [2 ]
Maattanen, L. [3 ]
Tammela, T. [4 ]
Ruutu, M. [1 ]
Auvinen, A. [5 ]
机构
[1] Univ Helsinki, Ctr Hosp, Dept Urol, Helsinki, Finland
[2] Pori Cent Hosp, Dept Surg, Pori, Finland
[3] Finnish Canc Registry, FIN-00170 Helsinki, Finland
[4] Tampere Univ Hosp, Dept Urol, Tampere, Finland
[5] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
关键词
D O I
10.1016/S1569-9056(10)60950-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:304 / 305
页数:2
相关论文
共 50 条
  • [31] Prostate cancers detected in the PSA interval 1.8-3 ng/mL - results from the Goteborg 2 prostate cancer screening trial
    Billig, Moller F.
    Mansson, M.
    Wallstrom, J.
    Hellstrom, M.
    Hugusson, J.
    Godtman, Arnsrud R.
    EUROPEAN UROLOGY, 2023, 83
  • [32] Screening for prostate cancer without digital rectal examination and transrectal ultrasound:: Results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
    Gosselaar, C
    Roobol, MJ
    Roemeling, S
    de Vries, SH
    van der Cruijsen-Koeter, I
    van der Kwast, TH
    Schröder, FH
    PROSTATE, 2006, 66 (06): : 625 - 631
  • [33] Specificity of prostate cancer screening with PSA:: Finnish ERSPC trial
    Tammela, TL
    Auvinen, A
    Määttänen, L
    Stenman, UH
    Ala-Opas, M
    Ruutu, M
    Juusela, H
    Hakama, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 431 - 431
  • [34] Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Herault
    Jegu, J.
    Tretarre, B.
    Grosclaude, P.
    Rebillard, X.
    Bataille, V.
    Malavaud, B.
    Iborra, F.
    Salama, G.
    Rischmann, P.
    Villers, A.
    PROGRES EN UROLOGIE, 2009, 19 (07): : 487 - 498
  • [35] ERSPC and PLCO Prostate Cancer Screening Studies: What Are the Differences?
    Schroder, Fritz H.
    Roobol, Monique J.
    EUROPEAN UROLOGY, 2010, 58 (01) : 46 - 52
  • [36] Characteristics of prostate cancers detected in a population-based screening study (ERSPC data, Rotterdam region)
    Rietbergen, JBW
    Kirkels, WJ
    Kranse, R
    Schroder, FH
    RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 173 - 178
  • [37] HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY - RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)
    Carlsson, Sigrid V.
    Aus, Gunnar
    Hugosson, Jonas
    JOURNAL OF UROLOGY, 2010, 183 (04): : E669 - E669
  • [38] Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data
    Heijnsdijk, E. A. M.
    de Carvalho, T. M.
    Auvinen, A.
    Zappa, M.
    Nelen, V.
    Kwiatkowski, M.
    Villers, A.
    Paez, A.
    Moss, S. M.
    Tammela, T. L. J.
    Recker, F.
    Denis, L.
    Carlsson, S. V.
    Wever, E. M.
    Bangma, C. H.
    Schroder, F. H.
    Roobol, M. J.
    Hugosson, J.
    de Koning, H. J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (01):
  • [39] HOW SCREENING DOES AFFECT ERECTILE FUNCTION AND URINARY CONTINENCE FOLLOWING RADICAL PROSTATECTOMY: RESULTS FROM THE EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE CANCER (ERSPC)
    Carlsson, S. V.
    Aus, G.
    Hugosson, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 302 - 302
  • [40] Digital rectal exam in prostate cancer screening: a critical review of the ERSPC Rotterdam study
    Bouras, Samir
    AFRICAN JOURNAL OF UROLOGY, 2024, 30 (01)